Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsDivislaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are a few investment ideas by SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy, Sell, Hold: Are these stocks present in your portfolio?

      Motilal Oswal has initiated coverage with a buy rating and has set a target price at Rs 229.

    • Expect 15-20% cut in Divis Labs' FY18-FY19 EPS estimates: HDFC Sec

      In an interview to CNBC-TV18, Amey Chalke, Pharma Analyst at HDFC Securities shared his readings and outlook on Divis Laboratories and Dr Reddys Laboratories.

    • Buy L&T, HUL; sell Apollo Hospitals, Idea Cellular; avoid Dr Reddy's Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy L&T and HUL and sell Apollo Hospitals and Idea Cellular while one can avoid Dr Reddy's Labs.

    • Buy Divis Laboratories on dips, strong support around Rs 723: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends buying Divis Laboratories on dips.

    • Here are fundamental ideas from Prakash Diwan

      Watch the interview of Prakash Diwan, Market Expert, Altamount Capital Management with Latha Venkatesh, Anuj Singhal, and Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

    • Fund managers are not gung-ho on these 20 stocks; do you have them in your portfolio?

      Rising liquidity in domestic MFs is one of the biggest factors in driving rally on D-Street which is trading at record highs.

    • Divis Labs can climb to Rs 810, HDFC Bank looks good: Gaba

      Prakash Gaba of prakashgaba.com is of the view that Divis Laboratories can climb to Rs 810 while HDFC Bank looks good.

    • Buy Divis Laboratories, sell Apollo Tyres: Sandeep Wagle

      According to Sandeep Wagle of powermywealth.com, one can buy Divis Laboratories and sell Apollo Tyres.

    • Buy Divis Labs, Bharat Financial Inclusion: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Divis Labs and Bharat Financial Inclusion.

    • Divis Labs can climb to Rs 810, Infosys looks weak: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Divis Laboratories can climb to Rs 810 while Infosys looks weak.

    • Buy Kotak Mahindra Bank, NMDC: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Kotak Mahindra Bank and NMDC.

    • Buy Bata India, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Bata India at current level.

    • Top trading ideas by SP Tulsian

      In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy Wockhardt, Divis Laboratories: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Wockhardt and Divis Laboratories.

    • Sell SBI, Pidilite, Dr Reddy's; buy TCS, Divis Labs: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell State Bank of India, Pidilite Industries and Dr Reddy's Laboratories and buy Tata Consultancy Services and Divis Laboratories.

    • Bull's Eye: Buy Sun Pharma, Siemens, Pidilite, Just Dial, DHFL

      Sumeet Jain of Destimoney Securities advises buying Castrol India with a target of Rs 454.

    • Here is why SP Tulsian is bullish on Petronet LNG

      SP Tulsian of sptulsian.com, explains why he is bullish on Petronet LNG. He also discusses key pharma sector likes Cadila Healthcare, Divis Laboratories and Aurobindo Pharma.

    • Avoid Divis Labs; buy Bharat Forge, Bharat Financial: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can avoid Divis Laboratories, Idea Cellular and Sun TV Network and buy Bharat Forge and Bharat Financial Inclusion.

    • Bharat Forge looks interesting, Hero Moto good bets: Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that Bharat Forge looks interesting while Hero Moto and Lupin are good bets for one-two days.

    • Buy Federal Bank, Glenmark, Divis Laboratories: Yogesh Mehta

      Yogesh Mehta of Motilal Oswal Securities suggests buying Federal Bank, Glenmark Pharma and Divis Laboratories.

    • Bull's Eye: Buy BoI, Titan, Divis Lab, Jindal Steel, KCP, IFCI

      Kunal Saraogi of Equityrush recommends buying Titan Company with a target of Rs 400 and Federal Bank with a target of Rs 87.

    • Divis Labs can climb to Rs 742, M&M Financial Rs 310: Gaba

      Prakash Gaba of prakashgaba.com is of the view that Divis Labs can climb to Rs 742 while Mahindra & Mahindra Financial Services may test Rs 310.

    • Bharat Financial looks good, like Divis Labs: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Bharat Financial looks good and likes Divis Laboratories.

    • Sell Hexaware; buy Adani Ports, Indiabulls Housing: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may sell Hexaware Technologies and Divis Labs and buy Adani Ports, Indiabulls Housing Finance and BHEL.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347